• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinoline carboxylic acids

Introduction to 2,6,8-Trimethylquinoline-4-carboxylic acid (CAS No. 93189-20-9)

2,6,8-Trimethylquinoline-4-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 93189-20-9, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical and chemical research. This compound belongs to the quinoline family, a class of nitrogen-containing aromatic organic compounds known for their diverse biological activities and applications in medicinal chemistry. The structural features of 2,6,8-Trimethylquinoline-4-carboxylic acid, characterized by its methyl substituents at the 2, 6, and 8 positions and a carboxylic acid group at the 4-position, contribute to its unique chemical properties and potential utility in synthetic chemistry and drug development.

The synthesis and characterization of 2,6,8-Trimethylquinoline-4-carboxylic acid have been subjects of extensive study due to its relevance in the development of novel therapeutic agents. Quinoline derivatives are well-documented for their antimicrobial, antimalarial, and anticancer properties. The introduction of methyl groups at specific positions in the quinoline core can modulate its pharmacokinetic behavior and enhance binding affinity to biological targets. Specifically, the carboxylic acid functionality at the 4-position provides a reactive site for further derivatization, enabling the construction of more complex molecules with tailored biological activities.

In recent years, advancements in computational chemistry and synthetic methodologies have facilitated the exploration of 2,6,8-Trimethylquinoline-4-carboxylic acid's potential applications. Researchers have leveraged molecular modeling techniques to predict how this compound might interact with enzymes and receptors involved in disease pathways. For instance, studies suggest that quinoline derivatives can inhibit kinases and other enzymes implicated in cancer progression. The structural flexibility of 2,6,8-Trimethylquinoline-4-carboxylic acid allows for the design of analogs that could target specific mutations or pathways more effectively than existing treatments.

One particularly promising area of research involves the use of 2,6,8-Trimethylquinoline-4-carboxylic acid as a precursor in the synthesis of metal-organic frameworks (MOFs) and coordination polymers. These materials are being explored for their potential in drug delivery systems due to their porous structures and tunable properties. The carboxylic acid group in 2,6,8-Trimethylquinoline-4-carboxylic acid can act as a ligand for metal ions, facilitating the assembly of complex architectures that could encapsulate therapeutic agents or enhance their release profiles.

The pharmaceutical industry has also shown interest in 2,6,8-Trimethylquinoline-4-carboxylic acid for its role as an intermediate in the synthesis of bioactive molecules. For example, researchers have investigated its use in creating inhibitors targeting bacterial resistance mechanisms. The quinoline scaffold is known to disrupt bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial replication. By modifying the quinoline core with substituents like methyl groups at specific positions,2,6,8-Trimethylquinoline-4-carboxylic acid can be transformed into compounds with enhanced efficacy against resistant strains.

In addition to its pharmaceutical applications,2,6,8-Trimethylquinoline-4-carboxylic acid has found utility in materials science. Its ability to form stable complexes with metals makes it a valuable component in catalytic systems used for organic transformations. These catalytic applications are particularly relevant in green chemistry initiatives aimed at reducing hazardous waste by replacing traditional heavy metal catalysts with more environmentally benign alternatives.

The chemical reactivity of 2,6,8-Trimethylquinoline-4-carboxylic acid allows for diverse functionalization strategies. Researchers have employed palladium-catalyzed cross-coupling reactions to introduce new substituents at various positions on the quinoline ring. Such modifications can fine-tune the electronic properties of the molecule and influence its interactions with biological targets. For instance,2-(pyridinyl)quinoxalines, derived from 2-methylquinoxaline, have shown promise as kinase inhibitors due to their ability to bind tightly to ATP-binding pockets.

The synthesis of 2-methylquinoxaline itself involves multi-step processes that often require careful optimization to achieve high yields and purity. One common approach involves condensation reactions between α-haloketones or α-halosulfonylketones with hydrazine derivatives under controlled conditions. These reactions typically proceed via nucleophilic addition followed by cyclization steps that form the quinoxaline core structure.

In conclusion,2-methylquinoxaline, along with related derivatives like 1-methylquinoxaline, represents an important class of heterocyclic compounds with broad applications spanning pharmaceuticals,organic electronics,and materials science. Their unique structural features enable versatile functionalization strategies that can be exploited for developing novel materials or therapeutic agents targeting various diseases including cancer,infectious diseases,and neurological disorders.

• 21240-71-1(3,5-dimethyl-7h-pyrido[2,3-c]carbazole-1-carboxylic Acid)
• 475098-86-3(2-methylquinoline-7-carboxylic acid)
• 590376-55-9(Methyl 2,8-dimethylquinoline-4-carboxylate)
• 104175-33-9(2,6-Dimethylquinoline-4-carboxylic acid)
• 103986-06-7(2,3-Dimethyl-1H-indole-6-carboxylic Acid)
• 14844-73-6(2,3-Dimethyl-1H-indole-5-carboxylic acid)
• 634-37-7(2-methylquinoline-8-carboxylic acid)
• 7120-25-4(2,3-dimethylquinoline-4-carboxylic acid)
• 634-38-8(2-Methylquinoline-4-carboxylic acid)
• 634-39-9(2-methylquinoline-5-carboxylic acid)